December 2019 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for December 2019. This roundup includes the latest...
APO(a)-LRX Found to Reduce Lipoprotein(a) Levels
Dose-dependent reduction found in patients with elevated lipoprotein(a) levels, cardiovascular disease
Diabetes Mellitus May Increase Risk for Developing Heart Failure
Increased risk for heart failure also seen in group of participants without diastolic dysfunction
Machine Learning System Makes More Alerts for Med Errors
68.2 percent of MedAware alerts would not have been generated with clinical decision support system
Poor Diet Contributes Substantially to Cardiometabolic Disease Costs
Diet tied to more than $50 billion in annual health care costs for heart disease, stroke, diabetes
High Lipoprotein(a) Is Risk Factor for CVD in Type 1 Diabetes
Lp(a) significant risk factor for macrovascular disease, albuminuria, calcified aortic valve disease
Multiple Health Benefits Reported for Intermittent Fasting
Review suggests health benefits can be attributed to more than just reduction in caloric intake
Exposure to Pyrethroid Insecticides Linked to Mortality
Risk increased for all-cause, CVD mortality for highest tertile of urinary 3-phenoxybenzoic acid
Machine Learning Model Helps Predict Risk for MI, Cardiac Death
Model integrates clinical and quantitative imaging-based variables to predict long-term cardiac risks
Recall of Pacemaker in Nov. 2015 Was Delayed Unnecessarily
Manufacturer and FDA were aware of battery and wire connection defects for 19 months before recall
